de la Torre-Aláez, Manuel http://orcid.org/0000-0002-1972-3933
Sangro, Bruno
Article History
Received: 16 May 2020
Accepted: 4 June 2020
First Online: 17 June 2020
Compliance with Ethical Standards
:
: Manuel de la Torre-Aláez (MdTA) received grants from Bayer. Bruno Sangro (BS) has received consulting fees from Adaptimmune, AstraZeneca, Bayer Bristol-Myers Squibb, BTG, H3 Biomedicine, Ipsen, Lilly, Roche, and Sirtex Medical; speakers' fees from Bayer Bristol-Myers Squibb, Ipsen, Lilly, and Sirtex Medical; and research funding from Bristol-Myers Squibb and Sirtex Medical.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, informed consent is not required.
: For this type of study, consent for publication is not required.